Carestream Unveils Next Generation Detector in Long-Length Digital Imaging

Carestream Health announces new innovations in its long-length imaging digital radiography (DR) detector that are aimed at improving patient comfort, productivity and efficiency.

The CARESTREAM DRX-LC Detector (Pending FDA 510(k) clearance) captures long-bone and spine images with a single exposure, making it ideal for pediatric imaging and long-bone and spine images of people with limited mobility. In contrast, the traditional multi-shot approach requires three to five exposures followed by manipulation and stitching of the images.

There are several key advancements in this next-generation long-length detector. The first is compatibility with DR mobile systems and mobile retrofits, in addition to X-ray rooms and room retrofits. The mobility of the system and its X-Factor capability allow facilities to use the same detector across multiple DRX systems for all phases of surgical treatment, from pre-planning imaging in the radiology department to capturing images during the procedure in the OR to confirm placement, and for post-operative assessment.

The versatile detector can be wireless or tethered. The wireless option eliminates trip hazards in the OR and minimizes the risk of contamination. The DRX-LC Detector has a Cesium (CsI) scintillator for better dose efficiency.

“Hospitals and clinics are looking for a better way to conduct long-length imaging exams that allow for lower dose, quicker exams and fewer repeats. The DRX-LC helps to minimize patient discomfort as the hold time is drastically reduced,” said Jill Hamman, Worldwide Marketing Manager, Global X-ray Solutions, at Carestream. “Its single shot ability also lowers radiation dose and the number of retakes due to patient movement. Further, an increase in image quality and precision provide a higher level of diagnostic confidence when planning treatment.”

The DRX-LC Detector uses ImageView Software, powered by Eclipse, the engine behind the company’s cutting-edge software platform that uses proprietary algorithms and artificial intelligence to amplify the value of the entire imaging chain.

The DRX-LC Detector meets the needs of a variety of facilities—from those that conduct several long-length exams to sites that see a high volume of patients.

“Single-shot long-length imaging delivers tangible improvements in patient comfort and workflow efficiency,” Ms. Hamman said. “The new wireless design, expanded system compatibility and mobile capacity of the DRX-LC Detector lets facilities expand their use of the system, maximizing their investment and bringing the benefits to more users.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.